These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36210658)

  • 1. Invasive and Non-invasive Ductal Carcinoma within Malignant Phyllodes Tumour with Axillary Lymph Node Metastases.
    Erdogan O; Parlakgumus A; Tas ZA; Yener K; Turan U
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):S92-S94. PubMed ID: 36210658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
    Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
    Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
    Han JS; Molberg KH; Sarode V
    Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant phyllodes tumour with intraductal and invasive carcinoma and lymph node metastasis.
    Korula A; Varghese J; Thomas M; Vyas F; Korula A
    Singapore Med J; 2008 Nov; 49(11):e318-21. PubMed ID: 19037540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
    Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
    Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can additional histopathological examination of ultrasound-guided axillary lymph node core biopsies improve preoperative diagnosis of primary breast cancer nodal metastasis?
    Mullen R; Purdie CA; Jordan LB; McLean D; Whelehan P; Vinnicombe S; Brown DC; Evans A
    Clin Radiol; 2013 Jul; 68(7):704-7. PubMed ID: 23518495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component.
    Wasserberg N; Morgenstern S; Schachter J; Fenig E; Lelcuk S; Gutman H
    Arch Surg; 2002 Nov; 137(11):1249-52. PubMed ID: 12413311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive Ductal Carcinoma within a Benign Phyllodes Tumor.
    Panko N; Jebran AA; Gomberawalla A; Connolly M
    Am J Case Rep; 2017 Jul; 18():813-816. PubMed ID: 28724885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Axillary Assessment of Ductal Carcinoma In Situ of the Breast Necessary in All Cases?
    Bellver G; Buch E; Ripoll F; Adrianzen M; Bermejo B; Burgues O; Julve A; Ortega J
    J Surg Res; 2022 Mar; 271():145-153. PubMed ID: 34902737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 13. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
    Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
    Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
    Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
    Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A rare clinical manifestation of a combination tumor of cystosarcoma phylloides malignum and an intraductal cancer].
    Schwickerath J; Blessing MH; Wolff F
    Geburtshilfe Frauenheilkd; 1992 Sep; 52(9):557-9. PubMed ID: 1327943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic "Ductal Carcinoma In Situ-Like" Lobular Carcinoma in a Lymph Node: A Case Report and Review of the Literature.
    Tijani S; Sharma K; Yuen H; Shaaban A
    Int J Surg Pathol; 2020 Jun; 28(4):436-439. PubMed ID: 31789065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.
    Guillot E; Vaysse C; Goetgeluck J; Falcou MC; Couturaud B; Fitoussi A; Fourchotte V; Laki F; Malhaire C; Sigal-Zafrani B; Sastre-Garau X; Bollet MA; Mosseri V; Reyal F
    Breast; 2014 Apr; 23(2):97-103. PubMed ID: 24388733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
    Ramzi S; Najeeb E; Coulthard J; Jenkins S
    Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern surgical treatment of breast cancer. 3rd Breast Cancer Consensus Conference].
    Lázár G; Bursics A; Farsang Z; Harsányi L; Kósa C; Maráz R; Mátrai Z; Paszt A; Pavlovics G; Tamás R
    Magy Seb; 2016 Sep; 69(3):117-32. PubMed ID: 27644928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
    Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ
    Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.